APA (7th ed.) Citation

Mirtorabi, S. H., Razavi, R., Mirjalili, R., Namiranian, N., Modarresi, M., & Azizi, R. (2024). Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Iranian Journal of Diabetes & Obesity (IJDO), 16(3), 149. https://doi.org/10.18502/ijdo.v16i3.16322

Chicago Style (17th ed.) Citation

Mirtorabi, Seyyed Hossein, Roghaye Razavi, Roghaye Mirjalili, Nasim Namiranian, Mozhgan Modarresi, and Reyhaneh Azizi. "Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study." Iranian Journal of Diabetes & Obesity (IJDO) 16, no. 3 (2024): 149. https://doi.org/10.18502/ijdo.v16i3.16322.

MLA (9th ed.) Citation

Mirtorabi, Seyyed Hossein, et al. "Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study." Iranian Journal of Diabetes & Obesity (IJDO), vol. 16, no. 3, 2024, p. 149, https://doi.org/10.18502/ijdo.v16i3.16322.